Neogen Corporation

neogen2

Neogen Profits Flat Despite Higher Sales

The Lansing biotech firm Neogen Corp. (Nasdaq: NEOG) Tuesday announced fiscal fourth quarter revenue of $48.5 million, up 11 percent from $43.6 million a year earlier. The company’s fiscal year ended May 31.

WWJ Newsradio 950–07/24/2012

Follow

Get every new post delivered to your Inbox.

Join 2,063 other followers